drugset / Trial / NCT00980876

A Comparative Study Between Two Formulations of the Ciprofloxacin Hydrochloride + Hydrocortisone Otic Suspension

NCT00980876

RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of this study is to compare the efficacy and safety profiles of the test product containing 2 mg/mL ciprofloxacin hydrochloride associated with 10 mg/mL of hydrocortisone with the reference product Cipro HC®, in patients with acute otitis externa.

Timeline

Start
2012-04
Primary completion
2015-01
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ciprofloxacin Small molecule 2 mg/ml Other
Subject Hydrocortisone Other / unclassified 10 mg/ml Other

Indications